Collectively, our obtained findings revealed that that miR-148a-3p delivered by glioma cells-derived exosomes could promote tumor angiogenesis by activating the EGFR/MAPK signaling pathway through inhibition of the ERRFI1 expression. The gene discussed is EGFR; the disease is central nervous system cancer.